63.44
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Small Cap Pro
Monthly Subscription
for only
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Genomic Health Inc | GHDX | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 63.44 | 19:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
63.44 | 63.44 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
61.13 | 94.19 | 33.06 | - | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 63.44 | USD |
Genomic Health Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 2.38B | 37.59M | 23.67M | $ 387.32M | $ 50.85M | 0.67 | 43.20 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | 22.00 | 5.50% |
Genomic Health News
Date | Time | Source | News Article |
---|---|---|---|
2/13/2020 | 06:03 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GHDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
3 Years | 35.73 | 92.18 | 30.04 | 63.12 | 401,625 | 27.71 | 77.55% |
5 Years | 30.20 | 92.18 | 22.00 | 53.34 | 269,642 | 33.24 | 110.07% |
Genomic Health Description
Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States. |